ArticleCancer biology & therapy2019

Prior exposure of pancreatic tumors to [sorafenib + vorinostat] enhances the efficacy of an anti-PD-1 antibody.

Laurence Booth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.